Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

43%

3 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 4

3(60.0%)

N/A

2(40.0%)

5Total

Phase 4(3)

N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT04246619Phase 4Terminated

Efficacy of Pregabalin and Duloxetine in Patients With PDPN: the Effect of Pain on Cognitive Function, Sleep and Quality of Life

Role: lead

NCT03738761Phase 4Completed

Management of Newly Diagnosed and Uncontrolled Hypertension With Fixed-Dose Combination of Perindopril/Amlodipine and Perindopril/Indapamide/Amlodipine

Role: lead

NCT04359966Not ApplicableUnknown

Prospective Randomised Trial of First and Second Line Treatments of RCT of First and Second Line H Pylori Treatments in Slovenia

Role: collaborator

NCT02831829Not ApplicableCompleted

Influence of Different Forms of Exercise Training in Patients With Coronary Artery Disease

Role: collaborator

NCT00761969Completed

Prevention of Ischemic Events in Patients With Peripheral Arterial Disease

Role: lead

NCT01147133Phase 4Completed

Comparison of Generic and Original Formulation of Clopidogrel

Role: collaborator

NCT00421239Completed

Risk Factors of Hypertensive Urgencies

Role: collaborator

All 7 trials loaded